Evidence map›Paper›PMID 37396701›Full record

ArticleThe Pan African medical journal2023

Molecular detection of SARS-CoV-2 infection in three geo-political zones of Nigeria: a cross-sectional study.

David Olufemi Olaleye, Adewale Victor Opayele, Hyacinth Chukwuebuka Egbuna, Adedayo Omotayo Faneye, Babatunde Adebiyi Olusola, Timothy Segun, Elizabeth Chibuzo Odeh, Magbagbeola David Dairo, Adeniyi Francis Fagbamigbe, Musa Adamu Sarki and 6 more

Abstract read
In one paragraph

Article in The Pan African medical journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

David Olufemi OlaleyeDepartment of Virology, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Adewale Victor OpayeleDepartment of Virology, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Hyacinth Chukwuebuka EgbunaDepartment of Public Health, Ministry of Health, Imo State, Nigeria.
Adedayo Omotayo FaneyeDepartment of Virology, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Babatunde Adebiyi OlusolaDepartment of Virology, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Timothy SegunDepartment of Medical Microbiology and Parasitology, College of Medicine, University of Lagos, Lagos, Nigeria.
Elizabeth Chibuzo OdehFederal University Teaching Hospital, Abakaliki, Ebonyi State, Nigeria.
Magbagbeola David DairoDepartment of Epidemiology and Medical Statistics, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Adeniyi Francis FagbamigbeDepartment of Epidemiology and Medical Statistics, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Musa Adamu SarkiAmino Kano University Teaching Hospital, Kano, Nigeria.
Maryam AminuDepartment of Microbiology, Ahmadu Bello University, Zaria, Nigeria.
Ademola Johnson AjuwonDepartment of Health Promotion and Education, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Olasumbo Ganiyu ArinolaDepartment of Immunology, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Chris Ezeora AchiEbonyi State Ministry of Health, Eboni, Nigeria.
Sunday Aremu OmilabuDepartment of Medical Microbiology and Parasitology, College of Medicine, University of Lagos, Lagos, Nigeria.
Georgina Njideka OdaiboDepartment of Virology, College of Medicine, University of Ibadan, Ibadan, Nigeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: sequel to the emergence of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its subsequent spread to all continents of the world, humans have continued to experience severe devastation to their health and economies. To control the spread of this virus, it is important to detect the infection in recently infected and asymptomatic individuals who are capable of infecting others. This study was designed to detect ongoing SARS-CoV-2 Infection among asymptomatic individuals in open markets across three geopolitical zones in Nigeria. Methods: nasal and oropharyngeal swab samples were collected from 2,158 study participants between December 20 Results: a total of 163 (7.6%) of the 2,158 participants enrolled for the study tested positive for SARS-CoV-2 by RT-PCR. The rate of infection was significantly higher in the North-western States of the country when compared to the western and Eastern regions (P=0.000). Similarly, the rate of infection was higher among buyers than sellers (P=0.000) and among males when compared with females, though the difference was not significant (p=0.31). Conclusion: this study shows that there is a continuous spread of SARS-CoV-2, especially among active, asymptomatic individuals across many States in the country. There is therefore need to continuously educate citizens on the need to adhere to both the non-pharmaceutical and pharmaceutical preventive measures to protect themselves and ultimately curb the spread of the virus.

Indexed as

COVID-19COVID-19 TestingCross-Sectional StudiesFemaleHumansMaleNigeriaSARS-CoV-2COVID-19marketsNigeriaSARS-CoV-2 infection

Identifiers

PMID37396701
PMCPMC10311229

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.